In tau-expressing transgenic mice, APOE4 exacerbated tau-mediated neurodegeneration, causing increases in brain atrophy and neuroinflammation, and alterations in glial cell function; this effect was seemingly independent of amyloid-beta pathology [66]. This evidence concerns the gene MAPT and Brain atrophy.